LEPPERTLAB - Key Persons
Endocrinologist Aaron Hsueh discovers obestatin, a hormone that supresses appetite and may lead to treatments for obesity.
Job Titles:
- EDUCATION PROGRAM MANAGER
Job Titles:
- EDUCATION EVENTS SPECIALIST
Job Titles:
- 2012 Resident Research Year
Pharmacologist Avram Goldstein discovers a chemical in the human brain that could lead to the development of powerful painkillers with fewer undesirable side effects.
Job Titles:
- CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY
Job Titles:
- ASSOCIATE DEAN, POST GRADUATE
Job Titles:
- PRESIDENT & CEO / STANFORD HEALTH CARE
Job Titles:
- Dean
- Physician
- Scientist
- Surgeon
- Carl and Elizabeth Naumann Dean of the School of Medicine
- CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY
- Vice Dean Linda M. Boxer
Dean Minor is a leading physician, basic scientist and educator.
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.
As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, "Discovering Precision Health," describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond - a multi-decade journey enabled by Precision Health.
In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.
Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.
With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
In 2012, Dr. Minor was elected to the National Academy of Medicine.
Carl and Elizabeth Naumann Dean of the School of Medicine,
Vice President for Medical Affairs, Stanford University,
Professor of Otolaryngology - Head and Neck Surgery, and Professor of Neurobiology and of Bioengineering, by courtesy
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor is also a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.
As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. He oversees the quality of Stanford Medicine's physicians on the faculty and in the organization's growing clinical networks and physician practices. In August 2023, Dr. Minor was appointed as Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.
Dr. Minor has demonstrated a steadfast commitment to diversity, equity, and inclusion. For example, between 2012 and 2022, the number of underrepresented students increased from 9.9 percent of incoming PhDs to 24.6 percent and from 14 percent of incoming MDs to 28.9 percent. Other key accomplishments include quadrupling the number of women department chairs and maintaining the highest NIH funding per faculty ratio in the country.
With Dr. Minor's leadership, Stanford Medicine is leading the biomedical revolution through Precision Health. Empowering people to lead healthy lives, Precision Health is a fundamental shift to more proactive and personalized health care that predicts and prevents disease before it strikes - and cures it decisively if it does. His book, "Discovering Precision Health: Predict, Prevent, and Cure to Advance Health and Well-Being," highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases.
Dr. Minor also spearheaded the creation of an Integrated Strategic Plan (ISP) that reaffirms Stanford Medicine's Precision Health vision. A groundbreaking roadmap launched in 2018, the ISP aligns Stanford Medicine's three entities, informs how each will develop strategies, and has activated dozens of high-impact initiatives across Stanford Medicine. In 2023, Dr. Minor and the CEOs of Stanford Health Care and Stanford Medicine Children's Health launched the ISP Refresh, an initiative focused on Stanford Medicine's evolution as it leads a biomedical landscape that has rapidly evolved due to COVID-19 and other developments.
At the beginning of the COVID-19 pandemic, Dr. Minor quickly implemented protocols to ensure the safety of patients and of the Stanford Medicine community. He emphasized open communication, transparency, and accountability as he and the leadership team responded to the unprecedented challenges that affected every facet of the enterprise's activities. Under his leadership, Stanford Medicine became one of the first academic medical centers to develop a COVID-19 test, launched hundreds of clinical research projects, and distributed 480,000 vaccine doses.
In 2021, Dr. Minor articulated and began realizing a bold vision for transforming the future of life sciences at Stanford University, in the Bay Area, and beyond. This multi-decade journey will leverage the region's unique strengths in information sciences, technology, and biology and biomedicine to establish a biomedical innovation hub that, through collaboration, enhances fundamental understanding of biology and translates promising discoveries into transformative leaps that promote human and planetary well-being.
Dr. Minor has long provided significant support for basic science research and for clinical and translational research at Stanford. Through bold initiatives in medical education and increased support for MD and PhD students, Dr. Minor is committed to inspiring and training future leaders. He also has increased student financial aid and expanded faculty leadership opportunities.
Among other accomplishments, Dr. Minor has led the development and implementation of an innovative model for cancer research and patient care delivery at Stanford Medicine and has launched an initiative in biomedical data science to harness the power of big data and create a learning health care system.
Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of The Johns Hopkins University. As provost, Dr. Minor launched many university-wide initiatives such as the Gateway Sciences Initiative to support pedagogical innovation, and the Doctor of Philosophy Board to promote excellence in PhD education. He worked with others around the university and health system to coordinate the Individualized Health Initiative, which aimed to use genetic information to transform health care.
Prior to his appointment as provost in 2009, Dr. Minor was the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in The Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. During his six-year tenure, he expanded annual research funding by more than half and increased clinical activity by more than 30 percent, while strengthening teaching efforts and student training.
With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. Through neurophysiological investigations of eye movements and neuronal pathways, his work has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning (the vestibulo-ocular reflex). The synergies between this basic research and clinical studies have led to improved methods for the diagnosis and treatment of balance disorders. In recognition of his work in refining a treatment for Ménière's disease, Dr. Minor received the Prosper Ménière Society's gold medal in 2010.
In the medical community, Dr. Minor is perhaps best known for his discovery of superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. In 1998, Dr. Minor and colleagues published a description of the clinical manifestations of the syndrome and related its cause to an opening (dehiscence) in the bone covering the superior canal. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
Dr. Minor received his bachelor's and medical degrees from Brown University. He trained at Duke University Medical Center and the University of Chicago Medical Center and completed a research fellowship at the University of Chicago and a clinical fellowship at The Otology Group and The EAR Foundation in Nashville, Tennessee.
In 2012, Dr. Minor was elected to the National Academy of Medicine.
As part of the Stanford Executive Briefing series, Minor shares his thoughts on authentic leadership and offers five leadership principles.
Sleep researcher Emmanuel Mignot identifies the defective gene that causes narcolepsy, a disabling sleep disorder affecting humans and animals.
Pathologist Eugene Butcher discovers a receptor that guides white blood cells into the peripheral lymph nodes.
Pathologist Gerald Crabtree develops techniques that allow scientists to toggle genes on and off in animal models.
Immunologist Hugh McDevitt discovers regulatory genes believed to control the body's reponses to foreign proteins, which suggests that people may have predictable susceptibility to certain diseases.
Pathologist Irving Weissman isolates a rare mouse cell, known as the hematopoetic stem cell, which gives rise to all the cells of the blood and immune systems.
Pathologist Irving Weissman identifies the stem cell that gives rise to bladder cancer, and also shows how the cell uses the "don't-eat-me" signal, a molecule known as CD47, to evade the body's defenses.
Pathologist Irving Weissman shows that a single antibody, which counters the effect of the CD47 molecule, shrinks a variety of human tumors transplanted into mice.
Job Titles:
- LEARNING PROJECT COORDINATOR
Job Titles:
- Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease
John Farquhar and Peter Wood lead the first large clinical investigation that shows lowering cholesterol levels prevents heart disease.
Job Titles:
- 2012 Resident Research Year
Job Titles:
- MHS - 2011 Resident Research Year
Lani has been playing the piano and composing music since she was 6 years old, and she has perfect pitch.
Pathologist Marius Wernig turns mouse skin cells into cells that insulate neurons with the application of just three genes.
Immunologist Mark Davis characterizes the T-cell receptor, believed to regulate the body's response to infectious agents and cancerous diseases.
Mary Gohlke receives the world's first combined heart and lung transplant in a landmark operation led by surgeon Bruce Reitz.
Job Titles:
- Executive Assistant to Dean Lloyd Minor, MD, Office of the Dean, Chief of Staff
Job Titles:
- WEBSITE COORDINATOR / WEB - DEVELOPER
Job Titles:
- Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease
Job Titles:
- 2013 Resident Research Year
Surgeon Roy Cohn leads the first human kidney transplant operation on the West Coast.
Job Titles:
- Member of the Lab
- 2016 Resident Research Year
Radiologist Sanjiv Gambhir develops a new type of imaging system that can illuminate tumors in living subjects with a precision of nearly one-trillionth of a meter
Job Titles:
- EDUCATION EVENTS / SPECIALIST
Pediatrician Thomas Robinson finds that children who curtailed their television time gained significantly less body fat than those who didn't .
Researcher William Haskell shows that intensive lifestyle changes and prevention/treatment programs can reduce cardiac events and slow the progression of atherosclerosis in coronary arteries.
Researcher William S. Robinson isolates the genetic blueprint of a virus that causes hepatitis B and a common form of liver cancer.